Meyka AI API is live for developers.Start building.
Advertisement
Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC (DCHPF) Stock Overview

Explore Dechra Pharmaceuticals PLC’s financial performance, market position, analyst ratings, and future outlook.

DCHPF●PNK
HealthcareMedical - Pharmaceuticals
$46.90
$0.10(0.21%)
U.S. Market opens in 47h 28m
Advertisement

Dechra Pharmaceuticals PLC (DCHPF)

Meyka AI Score

Z

Key Financials

Market Cap5.3B
P/E Ratio-143.06
EPS (TTM)$-0.31
ROE-0.04%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

DCHPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dechra Pharmaceuticals PLC (DCHPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -143.06 and a market capitalization of 5.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-0.89%
6-Month Change
3.65%
Year-to-Date (YTD) Change
45.44%
1-Year Change
39.79%
3-Year Change
3.08%
5-Year Change
19.80%
All-Time (Max) Change
196.84%

Contact Information

https://www.dechra.com
44 1606 814730
24 Cheshire Avenue, Northwich, NaN, CW9 7UA

Company Facts

24,570 Employees
IPO DateJul 11, 2016
CountryGB

Frequently Asked Questions